BCL10 Antikörper
Kurzübersicht für BCL10 Antikörper (ABIN2716548)
Target
Alle BCL10 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
Klon
-
-
Immunogen
- Full length human recombinant protein of human BCL10 (NP_003912) produced in HEK293T cell.
-
Isotyp
- IgG1
-
-
anti-B-Cell CLL/lymphoma 10 (BCL10) (AA 1-143) antibody
BCL10 Reaktivität: Human WB, FACS, IHC (p) Wirt: Maus Monoclonal 1185CT13-2-1-2 unconjugated
anti-B-Cell CLL/lymphoma 10 (BCL10) antibodyBCL10 Reaktivität: Human, Maus WB, IHC, ELISA, FACS, ICC Wirt: Maus Monoclonal 4F8 unconjugated
anti-B-Cell CLL/lymphoma 10 (BCL10) (AA 24-51), (N-Term) antibodyBCL10 Reaktivität: Human, Maus WB, IF, FACS, IHC (p) Wirt: Kaninchen Polyclonal RB24271 unconjugated
anti-B-Cell CLL/lymphoma 10 (BCL10) (AA 98-234) antibodyBCL10 Reaktivität: Human ELISA, FACS Wirt: Maus Monoclonal 3C11F4 unconjugated
anti-B-Cell CLL/lymphoma 10 (BCL10) (AA 122-168) antibodyBCL10 Reaktivität: Human WB, IHC, FACS, StM Wirt: Maus Monoclonal BL10-411 unconjugated
anti-B-Cell CLL/lymphoma 10 (BCL10) (AA 122-168) antibodyBCL10 Reaktivität: Human IHC, IF, FACS, StM Wirt: Kaninchen Monoclonal BL10-2988R unconjugated Recombinant Antibody
anti-B-Cell CLL/lymphoma 10 (BCL10) antibodyBCL10 Reaktivität: Human, Hund WB, IHC, IHC (p) Wirt: Maus Monoclonal 6A8 unconjugated
anti-B-Cell CLL/lymphoma 10 (BCL10) (AA 1-233) antibodyBCL10 Reaktivität: Human WB, IHC, ELISA Wirt: Kaninchen Polyclonal unconjugated
anti-B-Cell CLL/lymphoma 10 (BCL10) (AA 1-233) antibodyBCL10 Reaktivität: Human WB Wirt: Kaninchen Polyclonal unconjugated
anti-B-Cell CLL/lymphoma 10 (BCL10) antibodyBCL10 Reaktivität: Human, Maus, Ratte WB, IHC, ELISA Wirt: Kaninchen Polyclonal unconjugated
-
-
Applikationshinweise
- FC:1:50
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 0.5 mg/mL
-
-
- BCL10 (B-Cell CLL/lymphoma 10 (BCL10))
-
Andere Bezeichnung
- Bcl-10
-
NCBI Accession
- NM_003921
-
HGNC
- 8915
-
Pathways
- T-Zell Rezeptor Signalweg, Fc-epsilon Rezeptor Signalübertragung, Activation of Innate immune Response, Positive Regulation of Immune Effector Process, Production of Molecular Mediator of Immune Response, Tube Formation, Positive Regulation of Endopeptidase Activity, BCR Signaling, Ubiquitin Proteasome Pathway, S100 Proteine
Target
-
